“…Increased excretion of p-hydroxyphenylpyruvate, the product of tyrosine trans amination, occurs in rats and guinea pigs when the activity in liver of the transaminase is elevated relative to that of the oxidase which degrades this metabolite [16]. In human connective tissue diseases, the reported [23] excretion of an abnormal metabolite of tyrosine has been disproved [24], but the excretion of increased amounts of the normal metabolite, p-hydroxyphenylpyruvate, does occur [12]. Thus, an example of a non-specific effect of disease is the increased excretion in rheumatoid arthritis of metabolites of both tryptophan [22] and tyrosine [12].…”